IT'S impossible to escape the hype around weight-loss jabs. Whether that be the wild before-and-after pictures flooding social media. Or the feral gossip that follows everytime a celebrity posts a picture of themselves appearing to look slimmer than before.
And now, we're being faced with a barrage of studies claiming the jabs might be good for more than just shedding the pounds. Most recently, scientists said the medicines could be the cancer hope of the future, and after early studies suggested they could reduce the risk of tumours, for example. The jabs work by mimicking a hormone called GLP-1, which is normally released after eating.
This makes people feel full and reduces their appetite. Over the last few years, several medicines containing synthetic hormones have become available in the UK. Ozempic - whose active ingredient is semaglutide - is prescribed to treat type 2 diabetes and has the added benefit of making users lose weight.
Its manufacturer, Novo Nordisk, released a higher dose of semaglutide under the brand name Wegovy to treat obesity , which was rolled out in the UK last year. The Mounjaro KwikPen, which contains tirzepatide, has been approved by UK regulators as a diabetes and weight loss treatment. Another is liraglutide, which is prescribed on the NHS as Saxenda to tackle obesity , So, here are all the other benefits scientists are claiming the jabs might have.
Fat jabs could be the cancer hope of the future after early studies found they reduce the risk .
